Zai Lab (ZLAB) Total Non-Current Liabilities (2022 - 2026)

Zai Lab's (ZLAB) quarterly Total Non-Current Liabilities came in at $433.7 million in Q1 2026, up 19.73% year-on-year from $362.3 million in Q1 2025, and down 5.07% quarter-over-quarter from $456.9 million in Q4 2025.

Zai Lab (ZLAB) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Zai Lab has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $433.7 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $433.7 million, up 19.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $433.7 million (up 19.73% YoY), and the FY2025 annual result was $456.9 million, up 32.61% from the prior year.
  • Total Non-Current Liabilities came in at $433.7 million for Q1 2026 at Zai Lab, down from $456.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $456.9 million in Q4 2025 to a low of $162.4 million in Q3 2023.
  • The 5-year median for Total Non-Current Liabilities is $300.1 million (2024), against an average of $293.8 million.
  • Across the five-year window, Total Non-Current Liabilities surged 95.43% in 2024 and rose 19.73% in 2026, its largest moves.
  • Zai Lab's Total Non-Current Liabilities stood at $174.5 million in 2022, then jumped by 37.42% to $239.9 million in 2023, then soared by 43.64% to $344.5 million in 2024, then jumped by 32.61% to $456.9 million in 2025, then dropped by 5.07% to $433.7 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $433.7 million (Q1 2026), $456.9 million (Q4 2025), and $398.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn 433.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 433.72 Mn
Dec 31, 2025 456.88 Mn
Sep 30, 2025 398.67 Mn
Jun 30, 2025 372.04 Mn
Mar 31, 2025 362.25 Mn
Dec 31, 2024 344.53 Mn
Sep 30, 2024 317.35 Mn
Jun 30, 2024 282.86 Mn
Mar 31, 2024 225.94 Mn
Dec 31, 2023 239.85 Mn
Sep 30, 2023 162.39 Mn
Jun 30, 2023 173.73 Mn
Mar 31, 2023 168.51 Mn
Dec 31, 2022 174.55 Mn